Study reveals new pathway for brain tumor therapy

Study reveals new pathway for brain tumor therapy

In a new study led by Yale Cancer Center, researchers show the nucleoside transporter ENT2 may offer an unexpected path to circumventing the blood-brain barrier (BBB) and enabling targeted treatment of brain tumors with a cell-penetrating anti-DNA autoantibody. The study was published today online in the Journal of Clinical Investigation Insight.

Comments are closed.

New studies identify how tuberculosis processes destroy the lungs and how to protect them
15 June 2021
Drug rebates for insurers tied to higher costs for patients, especially the uninsured
15 June 2021